Espoo
Finland
22
2024-11-21
The entities that hold a legal rights for patent applications filed by inventor Hurme Reini:
Reini Hurme from Espoo, FI has applied for patents for these inventions. The list has both pending applications and granted patents:
LIPIDOMIC BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE
#2 | 2021-08-05Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#3 | 2021-01-07Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#4 | 2020-01-02Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#5 | 2019-03-21USE OF CERAMIDES AND LPLs IN DIAGNOSING CVD
#6 | 2018-11-08Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#7 | 2018-03-08Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#8 | 2017-06-08Use of ceramides and LPLs in diagnosing CVD
#9 | 2017-03-23BIOMARKERS FOR SENSITIVE DETECTION OF STATIN-INDUCED MUSCLE TOXICITY
#10 | 2016-12-15LIPIDOMIC BIOMARKERS FOR THE PREDICTION OF CARDIOVASCULAR OUTCOMES IN CORONARY ARTERY DISEASE PATIENTS UNDERGOING STATIN TREATMENT
#11 | 2016-12-15Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#12 | 2016-11-03Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
#13 | 2016-01-28Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#14 | 2015-09-17Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
#15 | 2015-09-17Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
#16 | 2015-09-03Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#17 | 2014-10-02Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
#18 | 2014-10-02Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
#19 | 2014-01-30Biomarkers for sensitive detection of statin-induced muscle toxicity
#20 | 2013-08-22Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#21 | 2013-02-21Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#22 | 2012-10-11Biomarkers for sensitive detection of statin-induced muscle toxicity
100334 ⎘